1.0000
-0.0100
(-0.99%)
At close: 4:00:00 PM EDT
0.9999
-0.00
(-0.01%)
After hours: 4:15:07 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -0.23 | -0.22 | -0.54 | -0.13 |
| Low Estimate | -0.23 | -0.22 | -0.54 | -0.13 |
| High Estimate | -0.23 | -0.22 | -0.54 | -0.13 |
| Year Ago EPS | -- | -- | -0.92 | -0.54 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 4 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | 0.00% | 0.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|
| EPS Est. | -- | -0.1 | -0.1 |
| EPS Actual | -0.64 | -0.13 | -0.28 |
| Difference | -- | -0.03 | -0.18 |
| Surprise % | -- | -30.00% | -180.00% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.23 | -0.22 | -0.54 | -0.13 |
| 7 Days Ago | 0 | 0 | -0.31 | -0.14 |
| 30 Days Ago | 0 | 0 | -0.31 | -0.14 |
| 60 Days Ago | 0 | 0 | -0.31 | -0.14 |
| 90 Days Ago | 0 | 0 | -0.31 | -0.14 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | 1 |
| Up Last 30 Days | -- | -- | -- | 1 |
| Down Last 7 Days | -- | -- | 1 | -- |
| Down Last 30 Days | -- | -- | 1 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| QNCX | -- | -- | 41.15% | 75.93% |
| S&P 500 | 6.40% | 6.07% | 9.36% | 14.28% |
Upgrades & Downgrades
| Maintains | D. Boral Capital: Buy to Buy | 3/25/2025 |
| Initiated | Oppenheimer: Outperform | 3/24/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 2/5/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 1/2/2025 |
| Initiated | Brookline Capital: Buy | 12/18/2024 |
| Maintains | D. Boral Capital: Buy to Buy | 11/14/2024 |
Related Tickers
DSGN Design Therapeutics, Inc.
2.8900
+3.58%
ZNTL Zentalis Pharmaceuticals, Inc.
1.2300
+8.85%
SPRB Spruce Biosciences, Inc.
0.2910
-1.39%
PMVP PMV Pharmaceuticals, Inc.
0.8720
+0.23%
EPIX ESSA Pharma Inc.
1.5800
+3.95%
THAR Tharimmune, Inc.
1.1500
+7.48%
ALZN Alzamend Neuro, Inc.
0.7672
-0.34%
KYTX Kyverna Therapeutics, Inc.
2.0600
+10.16%
LYEL Lyell Immunopharma, Inc.
0.4385
+5.69%
OLMA Olema Pharmaceuticals, Inc.
3.7700
+10.56%